Ernesto Oviedo-Orta

Company: BioCryst Pharmaceuticals Inc

Job title: Vice President


Exploring Factor D: A Potential New Target to Modulate and Treat Complement-Mediated Disease 3:10 pm

Identifying what makes Factor D an attractive target in complement disease Exploring the diseases relevant to Factor D inhibition Ongoing efforts in targeting Factor DRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.